Interpace OTC Stock Alpha and Beta Analysis

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Interpace Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Interpace Biosciences over a specified time horizon. Remember, high Interpace Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please see Interpace Biosciences Backtesting, Interpace Biosciences Valuation, Interpace Biosciences Correlation, Interpace Biosciences Hype Analysis, Interpace Biosciences Volatility, Interpace Biosciences History and analyze Interpace Biosciences Performance.
  
Please note that although Interpace Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Interpace Biosciences did 0.40  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Interpace Biosciences stock's relative risk over its benchmark. Interpace Biosciences has a beta of 0.35  . Let's try to break down what Interpace's beta means in this case. As returns on the market increase, Interpace Biosciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Interpace Biosciences will be expected to be smaller as well.
Interpace Biosciences Enterprise Value is projected to decrease significantly based on the last few years of reporting. The past year's Enterprise Value was at 38.78 Million. The current year Tangible Asset Value is expected to grow to about 28.4 M, whereas Enterprise Value over EBIT is forecasted to decline to (3.72) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Enterprise Value

41.84 Million

Interpace Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Interpace Biosciences market risk premium is the additional return an investor will receive from holding Interpace Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Interpace Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Interpace Biosciences' performance over market.
α-0.4   β0.35
90 days against NYA

Interpace Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Interpace Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Interpace Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Interpace Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Interpace Biosciences otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpace Biosciences shares will generate the highest return on investment. By understating and applying Interpace Biosciences otc stock market price indicators, traders can identify Interpace Biosciences position entry and exit signals to maximize returns.

Interpace Biosciences Return and Market Media

The median price of Interpace Biosciences for the period between Tue, Sep 6, 2022 and Mon, Dec 5, 2022 is 1.81 with a coefficient of variation of 15.29. The daily time series for the period is distributed with a sample standard deviation of 0.28, arithmetic mean of 1.83, and mean deviation of 0.21. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Interpace Biosciences Announces Third Quarter 2022 Financial...11/14/2022

About Interpace Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Interpace or other otcs. Alpha measures the amount that position in Interpace Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 (projected)
PPandE Turnover7.247.43
Long Term Debt to Equity0.0880.0903

Interpace Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Interpace Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Interpace Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Interpace Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Interpace Biosciences. Please utilize our Beneish M Score to check the likelihood of Interpace Biosciences' management manipulating its earnings.
Upcoming Quarterly Report30th of March 2022
Next Financial Report10th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End30th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Interpace Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Complementary Tools for analysis

When running Interpace Biosciences price analysis, check to measure Interpace Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpace Biosciences is operating at the current time. Most of Interpace Biosciences' value examination focuses on studying past and present price action to predict the probability of Interpace Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Interpace Biosciences' price. Additionally, you may evaluate how the addition of Interpace Biosciences to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Interpace Biosciences technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Interpace Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Interpace Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...